|
歐盟修訂甲基鹽霉素和尼卡巴嗪制劑的授權(quán)條款 食品伙伴網(wǎng)訊 據(jù)歐盟官方公報(bào)消息,2018年12月12日,歐盟委員會(huì)發(fā)布公告Commission Implementing Regulation (EU)2018/1957,該公告決定修訂甲基鹽霉素和尼卡巴嗪制劑(the preparation of narasin and nicarbazin)的授權(quán)條款以及實(shí)施細(xì)則(EU)No 885/2010的附錄。 法規(guī)(EC)No 885/2010的附錄修改如下:在第2欄中,‘Eli Lilly and Company Ltd’被‘Elanco GmbH’替代;在第4欄‘組成,化學(xué)式,描述,分析方法’,‘ 添加劑組合物 ’中,在微量示蹤劑紅的含量中, '11 g / kg‘被'4-11 g / kg’代替。 部分原文報(bào)道如下: Having regard to the Treaty on the Functioning of the European unio, Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition (1), and in particular Article 13(3) thereof, wheras: 。1)Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such authorisation. (2)The use of preparation of narasin and nicarbazin as a feed additive was authorised for 10 years for chickens for fattening by Commission Regulation (EU) No 885/2010 (2)。 |